Utama › Penyakit Kardiovaskular › Utah › Salt Lake City
Kajian klinikal Penyakit Kardiovaskular di Salt Lake City, UT
14 kajian untuk Penyakit Kardiovaskular sedang mencari peserta di lokasi dalam dan sekitar Salt Lake City (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
Harmony-HHT: ATV-1601 in Participants With Hereditary Hemorrhagic Telangiectasia (HHT)
Mengambil pesertaFasa 1/2Sukarelawan sihat dialu-alukan
- University of Utah Health Sciences Center, Salt Lake City
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
Mengambil pesertaFasa 3
- Olympus Family Medicine, Salt Lake City
Product Surveillance Registry
Mengambil pesertaKajian pemerhatian
- Salt Lake City, Salt Lake City
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
Mengambil pesertaFasa 3
- Clinical Trial Site, Salt Lake City
- Clinical Trial Site, Bountiful · 9 mi jauh
- Clinical Trial Site, Bountiful · 9 mi jauh
Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure
Mengambil peserta
- University of Utah, Salt Lake City
An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
Mengambil pesertaFasa 3
- The University of Utah, Salt Lake City
- Progressive Clinical Research, Bountiful · 9 mi jauh
Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older Adults
Mengambil pesertaFasa 4Sukarelawan sihat dialu-alukan
- VA Salt Lake City Healthcare System, Salt Lake City
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
Mengambil pesertaFasa 3
- Research Site, Bountiful · 9 mi jauh
Global Paradise System US Post Approval Study
Mengambil pesertaKajian pemerhatian
- St. Mark's Hospital, Salt Lake City
Study to Evaluate Safety, Tolerability and Efficacy of Inclisiran in Children With Homozygous Familial Hypercholesterolemia
Mengambil pesertaFasa 3
- Primary Childrens Medical Center, Salt Lake City
Optimizing Cardiovascular Preventive Care for Women Following Hypertensive Disorders of Pregnancy
Mengambil pesertaSukarelawan sihat dialu-alukan
- University of Utah Hospital, Salt Lake City
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
Mengambil peserta
- University of Utah Hospital, Salt Lake City
Study to Evaluate Efficacy and Safety of Inclisiran in Children With Heterozygous Familial Hypercholesterolemia
Mengambil pesertaFasa 3
- Primary Childrens Medical Center, Salt Lake City
- Primary Childrens Medical Center, Salt Lake City
Randomized Trial of SGLT2i in Heart Transplant Recipients
Mengambil pesertaFasa 4
- VA Salt Lake City Health Care System, Salt Lake City, UT, Salt Lake City
Kajian Penyakit Kardiovaskular di bandar lain
- Boston, MA37 kajian
- New York City, NY33 kajian
- Washington, DC28 kajian
- Houston, TX24 kajian
- Dallas, TX23 kajian
- Atlanta, GA22 kajian
- Cleveland, OH22 kajian
- Chicago, IL21 kajian
- Philadelphia, PA21 kajian
- Pittsburgh, PA20 kajian
- St. Louis, MO20 kajian
- Nashville, TN18 kajian
Kajian lain di Salt Lake City
- Kanser Paru-paru Bukan Sel Kecil31 kajian
- Kanser (semua jenis)27 kajian
- Kanser Payudara27 kajian
- Kanser Kolorektal22 kajian
- Kanser Paru-paru21 kajian
- Melanoma21 kajian
- Mieloma Pelbagai21 kajian
- Kanser Metastatik20 kajian
- Kanser Ovari19 kajian
- Obesiti18 kajian
- Leukemia Mieloid Akut17 kajian
- Kegagalan Jantung17 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.